Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6269
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs ; volume:23 ; number:3 ; day:13 ; month:2 ; year:2021 ; pages:1-13 ; date:3.2021
Current oncology reports ; 23, Heft 3 (13.2.2021), 1-13, 3.2021
- Creator
-
Joharatnam-Hogan, Nalinie
Alexandre, Leo
Yarmolinsky, James
Lake, Blossom
Capps, Nigel
Martin, Richard M.
Ring, Alistair
Cafferty, Fay
Langley, Ruth E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11912-021-01023-z
- URN
-
urn:nbn:de:101:1-2021050616310203336563
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Joharatnam-Hogan, Nalinie
- Alexandre, Leo
- Yarmolinsky, James
- Lake, Blossom
- Capps, Nigel
- Martin, Richard M.
- Ring, Alistair
- Cafferty, Fay
- Langley, Ruth E.
- SpringerLink (Online service)
Other Objects (12)
Targeting AMPK by Statins: A Potential Therapeutic Approach
Selecting women for breast cancer chemoprevention and what agents should be used
Biomarkers in cancer chemoprevention
Natural Products for Chemoprevention
Statins in Females
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Emerging therapeutic agents for genitourinary cancers
Emerging therapeutic agents for lung cancer
Evaluating embodied conversational agents in multimodal interfaces
Are statins anti-inflammatory?
Hepatotoxicity associated with statins
Independent association of Lp(a) with platelet reactivity in subjects without statins or antiplatelet agents
Targeting AMPK by Statins: A Potential Therapeutic Approach
Selecting women for breast cancer chemoprevention and what agents should be used
Biomarkers in cancer chemoprevention
Natural Products for Chemoprevention
Statins in Females
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Emerging therapeutic agents for genitourinary cancers
Emerging therapeutic agents for lung cancer
Evaluating embodied conversational agents in multimodal interfaces
Are statins anti-inflammatory?
Hepatotoxicity associated with statins
Independent association of Lp(a) with platelet reactivity in subjects without statins or antiplatelet agents
Targeting AMPK by Statins: A Potential Therapeutic Approach
Selecting women for breast cancer chemoprevention and what agents should be used
Biomarkers in cancer chemoprevention
Natural Products for Chemoprevention
Statins in Females
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Emerging therapeutic agents for genitourinary cancers
Emerging therapeutic agents for lung cancer
Evaluating embodied conversational agents in multimodal interfaces
Are statins anti-inflammatory?
Hepatotoxicity associated with statins